The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.
Amyloid Angiopathy and Variability in Amyloid β Deposition Is Determined by Mutation Position in Presenilin-1-Linked Alzheimer’s Disease
Open accessAbstract
The presenilins (PSs) are components of large molecular complexes that contain beta-catenin and function as gamma-secretase. We report here a striking correlation between amyloid angiopathy and the location of mutation in PS-1 linked Alzheimer's disease. The amount of amyloid beta protein, Abeta(42(43)), but not Abeta(40,) deposited in the frontal cortex of the brain is increased in 54 cases of early-onset familial Alzheimer's disease, encompassing 25 mutations in the presenilin-1 (PS-1) gene, compared to sporadic Alzheimer's disease. The amount of Abeta(40) in PS-1 Alzheimer's disease varied according to the copy number of epsilon4 alleles of the Apolipoprotein E gene. Although the amounts of Abeta(40) and Abeta(42(43)) deposited did not correlate with the genetic location of the mutation in a strict linear sense, the histological profile did so vary. Cases with mutations between codon 1 and 200 showed, in frontal cortex, many diffuse plaques, few cored plaques, and mild or moderate amyloid angiopathy. Cases with mutations occurring after codon 200 also showed many diffuse plaques, but the number and size of cored plaques were increased (even when epsilon4 allele was not present) and these were often clustered around blood vessels severely affected by amyloid angiopathy. Similarly, diverging histological profiles, mainly according to the degree of amyloid angiopathy, were seen in the cerebellum. Mutations in the PS-1 gene may therefore alter the topology of the PS-1 protein so as to favor Abeta formation and deposition, generally, but also to facilitate amyloid angiopathy particularly in cases in which the mutation lies beyond codon 200. Finally we report that the amount of Abeta(42(43)) deposited in the brain correlated with the amount of this produced in culture by cells bearing the equivalent mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several PSEN1 mutations are associated with AD and correlates with pathological CAA severity [610].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [610]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Wolfe, M. S., Xia, W., Ostaszewski, B. L., Diehl, T. S., Kimberly, W. T., & Selkoe, D. J. (1999) · Nature · doi:10.1038/19077 · Cited by 1,959
Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F. (1998) · Nature · doi:10.1038/34910 · Cited by 1,818
Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., & Ihara, Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90458-8 · Cited by 1,774
Self-citationIncreased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Pérez‐Tur, J., Hutton, M., Buée, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,486
Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Holcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-097 · Cited by 1,386
Amyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370
Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0197-67 · Cited by 1,271
Notch signaling is essential for vascular morphogenesis in micePreprint
Krebs, L. T., Xue, Y., Norton, C. R., Shutter, J. R., Maguire, M., Sundberg, J. P., Gallahan, D., Closson, V., Kitajewski, J., Callahan, R., et al. (2000) · Genes & Development · doi:10.1101/gad.14.11.1343 · Cited by 1,065
Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1
Li, Y.-M., Xu, M., Lai, M.-T., Huang, Q., Castro, J. L., DiMuzio-Mower, J., Harrison, T., Lellis, C., Nadin, A., Neduvelil, J. G., et al. (2000) · Nature · doi:10.1038/35015085 · Cited by 866
The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease
Selkoe, D. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01363-4 · Cited by 862
Presenilin 1 is linked with γ-secretase activity in the detergent solubilized state
Li, Y., Lai, M., Xu, M., Huang, Q., DiMuzio‐Mower, J., Sardana, M. K., Shi, X., Yin, K., Shafer, J. A., & Gardell, S. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.110126897 · Cited by 523
Dll4, a novel Notch ligand expressed in arterial endotheliumPreprint
Shutter, J. R., Scully, S. A., Fan, W., Richards, W. G., Kitajewski, J., Deblandre, G. A., Kintner, C. R., & Stark, K. L. (2000) · Genes & Development · doi:10.1101/gad.14.11.1313 · Cited by 518
Destabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis
Zhang, Z., Hartmann, H., Do, V. M., Abramowski, D., Sturchler, C., Staufenbiel, M., Sommer, B., van de Wetering, M., Clevers, H. C., Säftig, P., et al. (1998) · Nature · doi:10.1038/27208 · Cited by 515
Lemere, C. A., Lopera, F., Kosik, K. S., Lendon, C. L., Ossa, J., Saido, T. C., Yamaguchi, H., Ruiz, A., Martinez, A., Madrigal, L., et al. (1996) · Nature Medicine · doi:10.1038/nm1096-1146 · Cited by 487
Clark, R. F., Hutton, M., Fuldner, M., Froelich, S., Karran, E., Talbot, C., Crook, R., Lendon, C., Prihar, G., He, C., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-219 · Cited by 474
Self-citationTomita, T., Maruyama, K., Saido, T. C., Kume, H., Shinozaki, K., Tokuhiro, S., Capell, A., Walter, J., Grünberg, J., Haass, C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2025 · Cited by 385
Self-citationYu, G., Chen, F., Lévesque, G., Nishimura, M., Zhang, D., Lévesque, L., Rogaeva, E., Xu, D., Liang, Y., Duthie, M., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16470 · Cited by 366
Crook, R., Verkkoniemi, A., Pérez‐Tur, J., Mehta, N. D., Baker, M. C., Houlden, H., Farrer, M. J., Hutton, M., Lincoln, S., Hardy, J., et al. (1998) · Nature Medicine · doi:10.1038/nm0498-452 · Cited by 356
Capell, A., Grünberg, J., Pesold, B., Diehlmann, A., Citron, M., Nixon, R. A., Beyreuther, K. T., Selkoe, D. J., & Haass, C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3205 · Cited by 327
Embryonic lethality in mice homozygous for a processing-deficient allele of Notch1
Huppert, S. S., Le, A., Schroeter, E. H., Mumm, J. S., Saxena, M. T., Milner, L. A., & Kopan, R. (2000) · Nature · doi:10.1038/35016111 · Cited by 323
Presenilin 1 interaction in the brain with a novel member of the Armadillo family
Zhou, J., Liyanage, U. K., Medina, M., Ho, C., Simmons, A. D., Lovett, M., & Kosik, K. S. (1997) · Neuroreport · doi:10.1097/00001756-199705260-00054 · Cited by 296
Podlisny, M. B., Citron, M., Amarante, P., Sherrington, R., Xia, W., Zhang, J., Diehl, T. S., Levesque, G., Fraser, P., Haass, C., et al. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0129 · Cited by 296
Wolfe, M. S., Xia, W., Moore, C. L., Leatherwood, D. D., Ostaszewski, B., Rahmati, T., Donkor, I. O., & Selkoe, D. J. (1999) · Biochemistry · doi:10.1021/bi982562p · Cited by 289
Xia, W., Zhang, J., Kholodenko, D., Citron, M., Podlisny, M. B., Teplow, D. B., Haass, C., Seubert, P. A., Koo, E. H., & Selkoe, D. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7977 · Cited by 286
Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease
Wisniewski, H. M., Bancher, C., Barcikowska, M., Wen, G. Y., & Currie, J. (1989) · Acta Neuropathologica · doi:10.1007/bf00688170 · Cited by 220
Mann, D. M. A., Iwatsubo, T., Ihara, Y., Cairns, N. J., Lantos, P. L., Bogdanović, N., Lannfelt, L., Winblad, B. G., Maat–Schieman, M. L. C., & Rossor, M. N. (1996) · Europe PMC (PubMed Central) · Cited by 184
Self-citationMann, D. M. A., Iwatsubo, T., Cairns, N. J., Lantos, P. L., Nochlin, D., Sumi, S. M., Bird, T. D., Poorkaj, P., Hardy, J., Hutton, M., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410400205 · Cited by 184
Self-citationKwok, J. B., Taddei, K., Hallupp, M., Fisher, C., Brooks, W. S., Broe, G. A., Hardy, J., FULHAM, M. J., Nicholson, G. A., Stell, R., et al. (1997) · Neuroreport · doi:10.1097/00001756-199704140-00043 · Cited by 160
Presenilin-1 mutations in Alzheimer's disease
Russo, C., Schettini, G., Saido, T. C., Hulette, C. M., Lippa, C. F., Lannfelt, L., Ghetti, B. F., Gambetti, P., Tabaton, M., & Teller, J. K. (2000) · Nature · doi:10.1038/35014735 · Cited by 159
Direct association of presenilin‐1 with β‐catenin
Murayama, M., Tanaka, S., Palacino, J. J., Murayama, O., Honda, T., Sun, X., Yasutake, K., Nihonmatsu, N., Wolozin, B. L., & Takashima, A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00886-2 · Cited by 154
Berezovska, O., Xia, M., & Hyman, B. T. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199808000-00003 · Cited by 150
Presenilin-1 differentially facilitates endoproteolysis of the β-amyloid precursor protein and Notch
Capell, A., Steiner, H., Romig, H., Keck, S., Baader, M., Grim, M. G., Baumeister, R., & Haass, C. (2000) · Nature Cell Biology · doi:10.1038/35008626 · Cited by 148
Mann, D. M. A., Jones, D., Prinja, D., & Purkiss, M. (1990) · Acta Neuropathologica · doi:10.1007/bf00294651 · Cited by 148
Self-citationHyperaccumulation of FAD-linked presenilin 1 variants in vivo
Lee, M. K., Borchelt, D., Kim, G. J., Thinakaran, G., Slunt, H. H., Ratovitski, T., Martin, L. J., Kittur, A., Gandy, S., Levey, A. I., et al. (1997) · Nature Medicine · doi:10.1038/nm0797-756 · Cited by 148
Murayama, O., Tomita, T., Nihonmatsu, N., Murayama, M., Sun, X., Honda, T., Iwatsubo, T., & Takashima, A. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00187-1 · Cited by 130
Self-citationBroeckhoven, C. V., Backhovens, H., Cruts, M., Martin, J. J., Crook, R., Houlden, H., & Hardy, J. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90385-9 · Cited by 126
Aβ‐peptide length aid apolipoprotein E genotype in Alzheimer's disease
Gearing, M., Mori, H., & Mirra, S. S. (1996) · Annals of Neurology · doi:10.1002/ana.410390320 · Cited by 120
Phenotype of chromosome 14–linked familial Alzheimer's disease in a large kindred
Lampe, T. H., Bird, T. D., Nochlin, D., Nemens, E. J., Risse, S. C., Sumi, S. M., Koerker, R. M., Leaird, B., Wier, M., & Raskind, M. A. (1994) · Annals of Neurology · doi:10.1002/ana.410360308 · Cited by 102
Chromosome 14–encoded Alzheimer's disease: Genetic and clinicopathological description
Haltia, M., Viitanen, M. H., Sulkava, R. O., Ala‐Hurula, V., Pöyhönen, M., Goldfarb, L. G., Brown, P., Levy, E., Houlde, H., Crook, R., et al. (1994) · Annals of Neurology · doi:10.1002/ana.410360307 · Cited by 98
Variant Alzheimer’s disease with spastic paraparesis
Verkkoniemi, A., Somer, M., Rinne, J. O., Myllykangas, L., Crook, R., Hardy, J., Viitanen, M. H., Kalimo, H., & Haltia, M. (2000) · Neurology · doi:10.1212/wnl.54.5.1103 · Cited by 96
Presenilin 1 interaction in the brain with a novel member of the Armadillo family
Zhou, J., Liyanage, U. K., Medina, M., Ho, C., Simmons, A. D., Lovett, M., & Kosik, K. S. (1997) · Neuroreport · doi:10.1097/00001756-199704140-00033 · Cited by 96
Busciglio, J. A., Hartmann, H., Lorenzo, A., Wong, C. W., Baumann, K., Sommer, B., Staufenbiel, M., & Yankner, B. A. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-13-05101.1997 · Cited by 91
Elder, G. A., Tezapsidis, N., Carter, J. E., Shioi, J., Bouras, C., Li, H. ‐., Johnston, J. M., Efthimiopoulos, S., Friedrich, V. L., & Robakis, N. K. R. K. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19960801)45:3 · Cited by 91
Mann, D. M. A., Iwatsubo, T., Pickering-Brown, S. M., Owen, F., Saido, T. C., & Perry, R. H. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13294-8 · Cited by 91
Self-citationEarly‐onset Alzheimer's disease in 2 large Belgian families
Martin, J. J., Gheuens, J., Bruyland, M., Cras, P. P., Vandenberghe, A., Masters, C. L., Beyreuther, K. T., Dom, R., Ceuterick, C., Lübke, U., et al. (1991) · Neurology · doi:10.1212/wnl.41.1.62 · Cited by 83
A novel presenilin‐1 mutation: Increased β‐amyloid and neurofibrillary changes
Gómez‐Isla, T., Wasco, W., Pettingell, W. P., Gurubhagavatula, S., Schmidt, S. D., Jondro, P. D., McNamara, M. J., Rodes, L., Di-Blasi, T., Growdon, W. B., et al. (1997) · Annals of Neurology · doi:10.1002/ana.410410618 · Cited by 77
Function and Dysfunction of the Presenilins
Sisodia, S. S., Kim, S. H., & Thinakaran, G. (1999) · The American Journal of Human Genetics · doi:10.1086/302475 · Cited by 76
Shirayoshi, Y., Yuasa, Y., Suzuki, T., Sugaya, K., Kawase, E., Ikemura, T., & Nakatsuji, N. (1997) · Genes to Cells · doi:10.1046/j.1365-2443.1997.d01-310.x · Cited by 67
Cole, G., Neal, J. W., Singhrao, S. K., Jasani, B., & Newman, G. R. (1993) · Acta Neuropathologica · doi:10.1007/bf00230495 · Cited by 63
Alzheimer disease PS-1 exon 9 deletion defined
Prihar, G., Verkkoniem, A., Pérez‐Tur, J., Crook, R., Lincoln, S., Houlden, H., Somer, M., Paetau, A. E., Kalimo, H., Grover, A., et al. (1999) · Nature Medicine · doi:10.1038/13383 · Cited by 60
High levels of amyloid-β protein from S182 (Glu246) familial Alzheimerʼs cells
Martins, R. N., Turner, B. A., Carroll, R. T., Sweeney, D. A., Kim, K. S., Wı́sniewski, H. M., Blass, J. P., Gibson, G. E., & Gandy, S. (1995) · Neuroreport · doi:10.1097/00001756-199512000-00052 · Cited by 52
Mann, D. M. A., & Iwatsubo, T. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0017 · Cited by 52
Self-citationSplicing mutation of presenilin-1 gene for early-onset familial Alzheimer's disease
Sato, S., Kamino, K., Miki, T., Doi, A., Ii, K., George‐Hyslop, P. S., Ogihara, T., & Sakaki, Y. (1998) · Human Mutation · doi:10.1002/humu.1380110131 · Cited by 51
Presenilin‐1 protein expression in familial and sporadic Alzheimer's disease
Levey, A. I., Heilman, C. J., Lah, J. J., Nash, N. R., Rees, H. D., Wakai, M., Mirra, S. S., Rye, D. B., Nochlin, D., Bird, T. D., et al. (1997) · Annals of Neurology · doi:10.1002/ana.410410610 · Cited by 45
Ishii, K., Ii, K., Hasegawa, T., Shoji, S., Doi, A., & Mori, H. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00347-9 · Cited by 44
Mann, D. M. A., Takeuchi, A., Sato, S., Cairns, N. J., Lantos, P. L., Rossor, M. N., Haltia, M., Kalimo, H., & Iwatsubo, T. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2001.00316.x · Cited by 42
Self-citationHereditary Vascular Dementia Linked to Notch 3 Mutations: CADASIL in British Families
Thomas, N., Morris, C. M., Scaravilli, F., JOHANSSON, J., Rossor, M. N., LANGE, R. D., Clair, D. S., Nicoll, J. A. R., Blank, C., Coulthard, A., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06379.x · Cited by 34
Biology of presenilins as causative molecules for Alzheimer disease
Nishimura, M., Yu, G., & George‐Hyslop, P. S. (1999) · Clinical Genetics · doi:10.1034/j.1399-0004.1999.550401.x · Cited by 32
A presenilin-1 Thr116Asn substitution in a family with early-onset Alzheimerʼs disease
Romero, I., Jørgensen, P., Bolwig, G., Fraser, P. E., Rogaeva, E. A., Mann, D. M. A., Havsager, A., & Jørgensen, A. L. (1999) · Neuroreport · doi:10.1097/00001756-199908020-00006 · Cited by 30
Self-citationMann, D., Iwatsubo, T., & Snowden, J. S. (1996) · Acta Neuropathologica · doi:10.1007/s004010050479 · Cited by 29
Self-citationAmyloid plaques in the cerebellum in Alzheimer's disease.
Cole, G., Williams, P., Alldryck, D., & Singharo, S. (1989) · PubMed · Cited by 18
βA4 Amyloid Protein Deposition in the Cerebellum in Alzheimer's Disease and Down's Syndrome
Mackenzie, I. R., McKelvie, P. A., Beyreuther, K. T., & Masters, C. L. (1991) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107211 · Cited by 10
Research works printed but not linked: 2
- Mann, 1992, The time course of pathological events concerned with plaque formation in Down's syndrome with particular reference to the involvement of microglial cells, Neurodegeneration, 1, 201
- Perez-Tur, 1996, Identification of a mutation in Alzheimer's disease which destroys a splice acceptor site in the presenilin-1 gene, Neuroreport, 7, 204
Cited by
Sorted by citations
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994
Network abnormalities and interneuron dysfunction in Alzheimer disease
Palop, J. J., & Mucke, L. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.141 · Cited by 1,022
Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
Greenberg, S. M., Bacskai, B. J., Hernandez-Guillamon, M., Pruzin, J., Sperling, R., & van Veluw, S. J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0281-2 · Cited by 947
Alzheimer’s disease: A matter of blood–brain barrier dysfunction?
Montagne, A., Zhao, Z., & Zlokovic, B. V. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20171406 · Cited by 672
Bateman, R. J., Aisen, P. S., De Strooper, B., Fox, N. C., Lemere, C. A., Ringman, J. M., Salloway, S., Sperling, R. A., Windisch, M., & Xiong, C. (2010) · Alzheimer's Research & Therapy · doi:10.1186/alzrt59 · Cited by 573
Metadata
- Authors
- Mann, D. M. A., Pickering-Brown, S. M., Takeuchi, A., & Iwatsubo, T.
- Affiliations
- University of Manchester (GB)
- The University of Tokyo (JP)
- Corresponding author
- Mann, David M.A.
- Venue
- The American Journal of Pathology
- Publisher
- Elsevier BV
- Published
- 2001-06
- Volume
- 158
- Issue
- 6
- Pages
- 2165-2175
- ISSN
- 0002-9440 (ISSN-L)
- PMC
- PMC1891993
- OpenAlex
- W1965252410
- Cited by
- 182
- References
- 66
- Citations by year
- 2025: 2 · 2024: 13 · 2023: 7 · 2022: 11 · 2021: 10 · 2020: 5 · 2019: 6 · 2018: 7 · 2017: 4 · 2016: 7 · 2015: 12 · 2014: 2 · 2013: 8 · 2012: 6
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- American Journal Of Pathology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Keywords
- amyloid angiopathy, presenilin 1, Alzheimer's disease, amyloid-beta deposition, amyloid-beta 42, Aβ40, familial Alzheimer's disease, mutation position, APOE ε4, cerebral amyloid angiopathy, diffuse plaques, frontal cortex, cerebellum, gamma-secretase, protein topology
- MeSH terms
- Adult, Alzheimer Disease, Animals, Apolipoproteins E, Cerebellum, Female, Frontal Lobe, Genotype, Humans, Male, Membrane Proteins, Middle Aged, Mutation, Peptide Fragments, Genetic Variation, Amyloid beta-Peptides, Cerebral Amyloid Angiopathy, COS Cells, Presenilin-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review